Transfusion related acute lung injury (TRALI) is an uncommon complication following administration of blood products. It is often difficult to differentiate from other commoner causes of cardio-respiratory instability. However, prompt diagnosis and management is associated with favorable outcome.
Get full access to this article
View all access options for this article.
References
1.
SazamaK. Reports of 355 transfusion-associated deaths: 1976 through 1985. Transfusion1990;30:583–90.
2.
PopovskyMAAbelMDMooreSB. Transfusion-related acute lung injury associated with passive transfer of antileukocyte antibodies. Am Rev Respir Dis1983;128:185–9.
3.
KopkoPMMarshallCSMacKenzieMRHollandPVPopovskyMA. Transfusion-related acute lung injury: Report of a clinical look-back investigation. JAMA2002;287:1968–71.
4.
SillimanCCBoshkovLKMehdizadehkashiZElziDJDickeyWOPodloskyL. Transfusion-related acute lung injury: Epidemiology and a prospective analysis of etiologic factors. Blood2003:101:454–62.
5.
LooneyMRGropperMAMatthayMA. Transfusion-related acute lung injury: A review. Chest2004;126:249–58.
6.
WymanTHBjornsenAJElziDJSmithCWEnglandKMKelherM. A two-insult in vitro model of PMN-mediated pulmonary endothelial damage: Requirements for adherence and chemokine release. Am J Physiol Cell Physiol2002;283: C1592–603.
7.
KopkoPMPaglieroniTGPopovskyMAMutoKNMacKenzieMRHollandPV. TRALI: Correlation of antigen-antibody and monocyte activation in donor-recipient pairs. Transfusion2003;43:177–84.
8.
PopovskyMAMooreSB. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion1985;25:573–7.
